QUALITATIVE RESEARCH TO UNDERSTAND THE LIVED EXPERIENCE OF PATIENTS WITH DRY EYE DISEASE (DED), MEIBOMIAN GLAND DYSFUNCTION (MGD), AND SJOGREN'S SYNDROME DRY EYE DISEASE (SS-DED)

被引:0
|
作者
Sloesen, B. [1 ]
Young, A. [2 ]
Tinsley, K. [2 ]
Sharp, R. [2 ]
Walsh, O. [3 ]
Naujoks, C. [4 ]
Sharma, G. [5 ]
O'Brien, P. [6 ]
Bentley, S. [7 ]
机构
[1] Novartis Pharma NV, Vilvoorde, Belgium
[2] Adelphi Values Ltd, Bollington, Cheshire, England
[3] Novartis Ireland Ltd, Dublin, Ireland
[4] Novartis Pharma AG, Basel, BS, Switzerland
[5] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[6] Novartis, Limerick, LK, Ireland
[7] Adelphi Values Patient Ctr Outcomes Ltd, Bollington, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR89
引用
收藏
页码:S407 / S408
页数:2
相关论文
共 50 条
  • [1] CONTENT VALIDITY ASSESSMENT OF A NEWLY-DEVELOPED PATIENT-REPORTED OUTCOME MEASURE FOR DRY EYE DISEASE (DED), MEIBOMIAN GLAND DYSFUNCTION (MGD), AND SJOGREN'S SYNDROME DRY EYE DISEASE (SS-DED)
    Sloesen, B.
    Young, A.
    Hodson, N.
    Smith, V
    Walsh, O.
    Naujoks, C.
    Sharma, G.
    O'Brien, P.
    Arbuckle, R.
    VALUE IN HEALTH, 2022, 25 (12) : S394 - S395
  • [2] Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjogren's syndrome dry eye disease
    Sloesen, Brigitte
    Young, Alyson
    Forde, Katie
    Hodson, Nicola
    Bentley, Sarah
    Walsh, Oonagh
    Naujoks, Christel
    O'Brien, Paul
    Sharma, Garima
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [3] Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED) in the United States (US)
    Chester, Thomas
    Longo, Roberta
    Masseria, Cristina
    Riley, Phoenix
    Patel, Chad
    Mody, Lorie
    EXPERT REVIEW OF OPHTHALMOLOGY, 2025, 20 (01) : 55 - 61
  • [4] Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)-related dry eye disease (DED): a systematic review and meta-analysis
    Lei, Yahui
    Peng, Jing
    Liu, Jiayan
    Zhong, Jingxiang
    LASERS IN MEDICAL SCIENCE, 2022, 38 (01)
  • [5] Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)–related dry eye disease (DED): a systematic review and meta-analysis
    Yahui Lei
    Jing Peng
    Jiayan Liu
    Jingxiang Zhong
    Lasers in Medical Science, 38
  • [6] Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren’s syndrome dry eye disease
    Brigitte Sloesen
    Alyson Young
    Katie Forde
    Nicola Hodson
    Sarah Bentley
    Oonagh Walsh
    Christel Naujoks
    Paul O’Brien
    Garima Sharma
    Journal of Patient-Reported Outcomes, 7
  • [7] Manifestation of meibomian gland dysfunction in patients with Sjogren's syndrome, non-Sjogren's dry eye, and non-dry eye controls
    Kang, Yeon Soo
    Lee, Hyo Seok
    Li, Ying
    Choi, Won
    Yoon, Kyung Chul
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (03) : 1161 - 1167
  • [8] Meibomian Gland Disease The Role of Gland Dysfunction in Dry Eye Disease
    Chhadva, Priyanka
    Goldhardt, Raquel
    Galor, Anat
    OPHTHALMOLOGY, 2017, 124 (11) : S20 - S26
  • [9] Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjogren's syndrome
    Sullivan, DA
    Schaumberg, DA
    Suzuki, T
    Schirra, F
    Liu, M
    Richards, S
    Sullivan, RM
    Dana, MR
    Sullivan, BD
    LUPUS, 2002, 11 (10) : 667 - 667
  • [10] Sjogren's Patients' Experiences and Content Validity of the Dry Eye Disease Symptom Questionnaire (DED-SQ)
    Kruzikas, Denise
    Eldred, Ann
    Kafka, Shelly
    Church, Janet
    Hammitt, Katherine
    Koochaki, Patricia
    O'Donnell, Christina
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2384 - 2385